341
Views
10
CrossRef citations to date
0
Altmetric
Review

Novel immunotherapy combinations for genitourinary cancers

, ORCID Icon &
Pages 253-262 | Received 23 Aug 2019, Accepted 06 Jan 2020, Published online: 27 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alessia Cimadamore, Alessandro Rizzo, Veronica Mollica, Francesco Massari, Antonio Lopez-Beltran, Marina Scarpelli, Liang Cheng, Matteo Santoni & Rodolfo Montironi. (2021) An update on immunotherapy in uro-oncology. Expert Review of Precision Medicine and Drug Development 6:4, pages 229-233.
Read now

Articles from other publishers (9)

Moulay Mustapha Ennaji. 2023. Immunological Implications and Molecular Diagnostics of Genitourinary Cancer. Immunological Implications and Molecular Diagnostics of Genitourinary Cancer 1 3 .
Daniel Sentana‐Lledo, Oliver Sartor, Steven P. Balk & David J. Einstein. (2022) Immune mechanisms behind prostate cancer in men of African ancestry: A review. The Prostate 82:8, pages 883-893.
Crossref
Siddharth Menon, Sagun Parakh, Andrew M. Scott & Hui K. Gan. (2022) Antibody-drug conjugates: beyond current approvals and potential future strategies. Exploration of Targeted Anti-tumor Therapy, pages 252-277.
Crossref
Alessandro Rizzo, Veronica Mollica, Matteo Santoni, Angela Dalia Ricci, Gennaro Gadaleta-Caldarola, Rodolfo Montironi & Francesco Massari. (2022) Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysis. Future Oncology 18:6, pages 739-748.
Crossref
Davide Bimbatti, Marco Maruzzo, Francesco Pierantoni, Alberto Diminutto, Michele Dionese, Filippo M. Deppieri, Eleonora Lai, Vittorina Zagonel & Umberto Basso. (2022) Immune checkpoint inhibitors rechallenge in urological tumors: An extensive review of the literature. Critical Reviews in Oncology/Hematology 170, pages 103579.
Crossref
Alessandro Rizzo, Veronica Mollica & Francesco Massari. (2022) Expression of Programmed Cell Death Ligand 1 as a Predictive Biomarker in Metastatic Urothelial Carcinoma Patients Treated with First-line Immune Checkpoint Inhibitors Versus Chemotherapy: A Systematic Review and Meta-analysis. European Urology Focus 8:1, pages 152-159.
Crossref
Melika Shafeghat, Maryam Balibegloo & Nima Rezaei. 2022.
Mirazkar D. Pandareesh, Vivek H. Kameshwar & Kullaiah Byrappa. (2021) Prostate Carcinogenesis: Insights in Relation to Epigenetics and Inflammation. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:2, pages 253-267.
Crossref
Veronica Mollica, Alessandro Rizzo, Rodolfo Montironi, Liang Cheng, Francesca Giunchi, Riccardo Schiavina, Matteo Santoni, Michelangelo Fiorentino, Antonio Lopez-Beltran, Eugenio Brunocilla, Giovanni Brandi & Francesco Massari. (2020) Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial Carcinoma. Cancers 12:6, pages 1449.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.